Aflac (AFL, Life & Health Insurance) Stock Valuation & Fair Value Significantly overvalued
Aflac (AFL, Life & Health Insurance) trades at a blended P/E of 16.8 — about 43% above its historical normal valuation — with a forward growth estimate of 4.0% and a PEG of 4.17. Analysts' one-year estimates have been hit 55% of the time.
Valuation flags
- Overvalued by 43%
- High PEG (4.2x)
- Low growth forecast
Verdict history
tickerseer's rating moved from trading above fair value (2026-06-10) to significantly overvalued (2026-07-14).
Frequently asked questions
Is Aflac stock overvalued?
At a blended P/E of 16.8 versus its historical normal P/E of 11.8, Aflac trades about 43% above its typical valuation, with a PEG of 4.17 on 4.0% forward growth — tickerseer currently rates it significantly overvalued.
What is Aflac's fair value and PEG?
Aflac trades at a blended P/E of 16.8 against a historical normal P/E of 11.8, a PEG of 4.17, and a forward growth estimate of 4.0%.
Has tickerseer's rating of Aflac changed?
tickerseer's rating moved from trading above fair value (2026-06-10) to significantly overvalued (2026-07-14).
Industry: Life & Health Insurance. Create a free account to unlock the full analysis — the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.